Related Experiment Video
Updated: Sep 30, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers
1Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
Radiation therapy remains an important component of cancer treatment. Gene-encoded proteins were the actual executors of cellular functions. Proteomic was a novel technology that can systematically analysis protein composition and measure their levels of change, this was a high throughput method, and were the import tools in the post genomic era. In recent years, rapid progress of proteomic have been made in the study of cancer mechanism, diagnosis, and treatment. This article elaborates current advances and future directions of proteomics in the discovery of radiosensitive cancer biomarkers.
Insights
Proteomics, the study of proteins, is advancing cancer treatment by identifying biomarkers for radiation sensitivity. This technology helps discover new ways to improve radiation therapy effectiveness in cancer patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Radiation therapy is a cornerstone of cancer treatment.
- Proteomics offers a high-throughput method to analyze protein composition and changes.
- Understanding protein roles is crucial for cellular functions and cancer mechanisms.
Purpose of the Study:
- To elaborate on the advances in proteomics for cancer research.
- To explore the future directions of proteomics in identifying radiosensitive cancer biomarkers.
- To highlight the role of proteomics in cancer diagnosis and treatment.
Main Methods:
- Systematic analysis of protein composition.
- Measurement of protein level changes using high-throughput proteomic techniques.
- Review of recent progress in proteomic applications for cancer.
Main Results:
- Proteomics has made significant progress in understanding cancer mechanisms.
- Proteomic approaches are valuable tools in the post-genomic era for cancer studies.
- This field is crucial for discovering biomarkers related to radiosensitivity.
Conclusions:
- Proteomics is a rapidly advancing field with significant implications for cancer treatment.
- The discovery of radiosensitive biomarkers through proteomics can enhance radiation therapy efficacy.
- Future research directions lie in leveraging proteomics for personalized cancer medicine.
More Related Videos
08:08Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...